Intellectual Property India Publishes Patent Application for Mitochondria-Targeted Antioxidants For Use In The Treatment Of Cell Balloooning-Associated Diseases, Such As Non-Alcoholic Fatty Liver Disease (nafld) And Non-Alcoholic Steatohepatitis (nash)

MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202617059182 A) filed by Mitotech S. A. on May 09, 2026, for Mitochondria-Targeted Antioxidants For Use In The Treatment Of Cell Balloooning-Associated Diseases, Such As Non-Alcoholic Fatty Liver Disease (nafld) And Non-Alcoholic Steatohepatitis (nash).

Inventors include Skulachev, Maxim; and Petrov, Anton.

The application for the patent was published on September 11, 2026, under issue no. 37/2026.

Abstract: Methods and compositions for treating and preventing cell ballooning and other diseases or medical conditions are provided. The diseases or medical conditions are characterized by cell degeneration or cell death as a part of the disease pathogenesis. Cell ballooning is a condition associated with storage of excess fat in the liver. nutritional or biochemical imbalance, damage to mitochondria, ATP depletion, or virus infection. A mitochondrially targeted antioxidant compound is administered to a subject in need thereof, whereby excess fat is metabolized.

Disclaimer: Curated by HT Syndication.